Aaron Logan
Cited by
Cited by
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications
V Yank, CV Tuohy, AC Logan, DM Bravata, K Staudenmayer, R Eisenhut, ...
Annals of Internal Medicine 154 (8), 529-540, 2011
High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment
AC Logan, H Gao, C Wang, B Sahaf, CD Jones, EL Marshall, I Buño, ...
Proceedings of the National Academy of Sciences 108 (52), 21194-21199, 2011
Off-label use of recombinant factor VIIa in US hospitals: analysis of hospital records
AC Logan, V Yank, RS Stafford
Annals of internal medicine 154 (8), 516-522, 2011
Factors influencing the titer and infectivity of lentiviral vectors
AC Logan, SJ Nightingale, DL Haas, GJ Cho, KA Pepper, DB Kohn
Human gene therapy 15 (10), 976-988, 2004
Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia
AC Logan, B Zhang, B Narasimhan, V Carlton, J Zheng, M Moorhead, ...
Leukemia 27 (8), 1659-1665, 2013
Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia
C Gawad, F Pepin, VEH Carlton, M Klinger, AC Logan, DB Miklos, ...
Blood 120 (22), 4407-4417, 2012
Advances in lentiviral vector design for gene-modification of hematopoietic stem cells
AC Logan, C Lutzko, DB Kohn
Current opinion in biotechnology 13 (5), 429-436, 2002
Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration
AC Logan, DL Haas, T Kafri, DB Kohn
Journal of virology 78 (16), 8421-8436, 2004
Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse …
AC Logan, N Vashi, M Faham, V Carlton, K Kong, I Buño, J Zheng, ...
Biology of Blood and Marrow Transplantation 20 (9), 1307-1313, 2014
Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia
BK Masouleh, H Geng, C Hurtz, LN Chan, AC Logan, MS Chang, ...
Proceedings of the National Academy of Sciences 111 (21), E2219-E2228, 2014
Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT
CE Ryan, B Sahaf, AC Logan, S O’Brien, JC Byrd, P Hillmen, JR Brown, ...
Blood 128 (25), 2899-2908, 2016
Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.
DW Sherbenou, BT Aftab, Y Su, CR Behrens, A Wiita, AC Logan, ...
The Journal of clinical investigation 126 (12), 4640-4653, 2016
Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting
AC Logan, LT Goodnough
ASH Education Program Book 2010 (1), 153-159, 2010
The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells
DL Haas, C Lutzko, AC Logan, GJ Cho, D Skelton, XJ Yu, KA Pepper, ...
Journal of virology 77 (17), 9439-9450, 2003
The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: Why the quest for meaningful prophylaxis still matters
ST Chan, AC Logan
Blood Reviews, 2017
Hemophagocytic lymphohistiocytosis in pregnancy: a case report and review of treatment options
T Dunn, M Cho, B Medeiros, A Logan, A Ungewickell, M Liedtke
Hematology 17 (6), 325-328, 2012
ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation
AC Logan, Z Wang, K Alimoghaddam, RM Wong, T Lai, RS Negrin, ...
Biology of Blood and Marrow Transplantation 21 (4), 746-754, 2015
Multicenter open-label phase 2 study of ibrutinib in chronic graft versus host disease (cGVHD) after failure of corticosteroids
D Miklos, CS Cutler, M Arora, EK Waller, M Jagasia, I Pusic, ME Flowers, ...
Blood 128 (22), LBA-3-LBA-3, 2016
The road to purified hematopoietic stem cell transplants is paved with antibodies
AC Logan, IL Weissman, JA Shizuru
Current opinion in immunology 24 (5), 640-648, 2012
Multigene measurable residual disease assessment improves acute myeloid leukemia relapse risk stratification in autologous hematopoietic cell transplantation
MP Mulé, GN Mannis, BL Wood, JP Radich, J Hwang, NR Ramos, ...
Biology of Blood and Marrow Transplantation 22 (11), 1974-1982, 2016
The system can't perform the operation now. Try again later.
Articles 1–20